Abstract
Background
Sixteen years is how long it took after the first proof-of-concept randomized clinical trial for endovascular treatment of stroke due to large vessel occlusion (LVO) to appear in the national guidelines [1, 2] . A meta-analysis of recent endovascular trials showed strong benefit overall among eligible subjects and in subgroups traditionally thought not to benefit or be at high risk of hemorrhagic complications, such as patients aged 70 years or older and patients with severe stroke (NIHSS > 20) [3] . Looking at them separately [4] [5] [6] [7] [8] or after pooling individual patient data [9] , the endovascular trials show that the shorter the time to treatment, the better the outcome. In fact, the most expeditious trial, ESCAPE [6] , was the only one to show mortality benefit despite being prematurely terminated before reaching its target sample size.
The current model of triaging patients with suspected stroke to the nearest IV alteplasecapable hospital (ACH) that does not have endovascular capability leads to inevitable delay for LVO patients as subsequent transport to an endovascular-capable hospital (ECH) is necessary. Delay may decrease the benefit of the procedure or preclude performing it if the patient arrives at the ECH after the treatment window has closed. One proposed model of triaging LVO patients to the nearest ECH even if it means bypassing a closer ACH, has been extensively debated for the last 2 years [10] . We conducted an online survey to gauge attitudes towards this proposed model among medical specialties involved in acute stroke management.
Method
The survey featured two cases of acute stroke with witnessed onset and paramedics arriving at the scene within the first hour from symptom onset. One patient had cortical signs (aphasia and gaze deviation) suggestive of LVO and the other hemiparesis and hemihypesthesia without cortical signs. For each, the responders were asked to choose whether to send the patient to the nearest ACH or the nearest ECH, if the latter is further, and to provide the maximum acceptable extra transport time to get to the ECH. Responders were instructed to select the option they think is in the best interest of the patient, regardless of their current practice.
The survey was created on the SurveyMonkey website (www.surveymonkey.com) and was electronically sent to: (a) the American Academy of Neurology (AAN) stroke/vascular neurology section online community, (b) the AAN endovascular/interventional neurology section online community, (c) listserve of emergency department (ED) physicians practicing in 3 hospitals affiliated with our academic institution (2 of them are level I trauma centers), (d) listserve of the American College of Emergency Physicians -Emergency Medical Service (EMS) physicians group, (e) the stroke centers coordinators in the state of Minnesota, and the coordinators of comprehensive stroke centers nationwide. The survey allowed the responders to specify other specialties or if still in training. Responses were collected for 3 weeks. Participants were not asked for and did not provide any personal identifying data. Participants were informed that the data would be presented publicly in an aggregated fashion. Participation was voluntary and consent was implied.
Results
There were 320 responses: 90 neurologists, 86 ED physicians, 61 EMS physicians, 35 stroke centers coordinators, 16 interventional neuroradiologists, 9 trainees (of any of the above-mentioned specialties), and 3 intensivists. Most responses were from the United States spanning 44 states. Half the sample practiced in an academic setting, half in a private setting, and 58% had more than 10 years of experience. In response to the LVO case, 72.5% of responders chose to send the patient to ECH, whereas in the case of non-LVO stroke, 56% of responders preferred sending the patient to ACH. When the responders were categorized according to their specialty, important differences emerged. The overwhelming majority of neurologists, 89%, supported triage of the LVO case to ECH and 71% supported triage of the non-LVO case to the ACH. Most ED and EMS physicians favored triaging both LVO and non-LVO to the ECH. Stroke coordinators had the most support for ACH with 49% favoring triaging LVO to the ACH and 71% favoring it in the non-LVO case. Interestingly, almost all groups agreed on the acceptable extra time to transport to ECH with a median of 30 min (Fig. 1) .
Discussion
Despite the lack of response rate, the survey results did provide new insight as to the attitudes of current practitioners across a wide geographical area. These providers have different but close perspectives. They all deal with ischemic stroke emergencies but have different roles. Recognizing, and, sanguinely, eventually harmonizing, the diversity of viewpoints is the rationale for this research. A large majority supported bypassing ACH when LVO was suspected despite the lack of randomized controlled trial proving that such a model would improve outcomes for LVO cases and not significantly penalize non-LVO patients delayed in receiving IV tPA by mistriage. This indicates that the responders believed that endovascular therapy is the optimal treatment modality for LVO patients with IV alteplase being less or even not important at all as suggested by a recent analysis [11] . The more surprising finding was that a sizable minority, 44%, supported triaging non-LVO case to the further ECH. Neurologists have the most internal agreement among themselves and there seems to be a clear dichotomy in triage decision based on probability of LVO. This may reflect the neurology specialty bias that LVO can be accurately differentiated from non-LVO on readily apparent clinical grounds, which is not always the case [12] . The only definitive way to exclude LVO is by vascular imaging. ED and EMS physicians preferred ECH for LVO and non-LVO cases. Whether this attitude is due to strong conviction about the benefit of endovascular therapy, fear of lack of adequate supportive care post IV thrombolysis (such as available neurocritical and neurosurgery care), or historical mistrust of alteplase is unclear. The stroke centers coordinators were the least supportive of the proposed triage model, perhaps reflecting concern about harm if IV alteplase is delayed and/or concern about ACH hospitals losing their local patients leading to deterioration of experience and practice. It is important to highlight that most patients in the endovascular arm of the positive endovascular trials (83%) were treated with IV alteplase before endovascular treatment.
The near unanimous agreement on the accepted extra transfer time to reach the further ECH being exactly 30 min, is another surprise. The basis of this cutoff is unknown. According to the Get-With-The-Guidelines data analysis by Saver et al. [13] , a 30-min delay could lead to 8 more patients dying out of every 1,000 patients treated with IV alteplase within a 4.5-h window. However, the effect of delay is not uniform across the 0-4.5-h time window as can be inferred by the difference in the number needed to treat to achieve excellent outcome: 4.5 in the first 90 min from symptom onset to 9 in the second 90 min and 14 in the third 90 min [14] .
This survey was conducted in mid-June 2017, about 5 months before the publication of the DAWN trial (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo) [15] , and it is possible that the responders' interpretation of this pivotal trial would impact the responses. On one end, DAWN has finally ended the era of utilizing time as surrogate marker for brain viability, which may reduce the anxiety about the time window, encouraging more to choose to triage patients to the closer ACH for alteplase administration followed by transfer to ECH. On the other hand, DAWN does not negate the important effect of time on loss of salvageable brain tissue as demonstrated by ASPECTS decay [16] , which would still argue with bypassing ACH in LVO patients.
Although most of the survey responders prefer triaging LVO stroke directly to the ECH, there is enough difference of opinion to declare a state of equipoise [17] . This equipoise is mainly driven by the lack of agreement in handling of non-LVO stroke, especially with the lack of a reliable tool to differentiate between the two.
Conclusion
In this survey of healthcare providers who routinely care for acute stroke patients, most responders favor bypassing hospitals without endovascular capabilities if LVO stroke is suspected, while there was disagreement on triaging patients whose strokes are not suspected to be due to LVO. This warrants a clinical trial, or a series of trials, to examine and refine different aspects of the proposed model first, then compare it with the current practice. Of critical importance is a triage tool of proven accuracy when used in the field by EMS providers. The comparative trials should be designed to show superiority rather than non-inferiority in order to drive a change in practice.
